{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T11:42:56Z","timestamp":1777981376773,"version":"3.51.4"},"reference-count":62,"publisher":"Scientific Scholar","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Palliat Care"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/0973-1075.285693","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T14:47:30Z","timestamp":1593182850000},"page":"180","source":"Crossref","is-referenced-by-count":3,"title":["Indian society for study of pain, cancer pain special interest group guidelines on pharmacological management of cancer pain (Part II)"],"prefix":"10.25259","volume":"26","author":[{"given":"RaghuS","family":"Thota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghavendra","family":"Ramanjulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arif","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parmanand","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen","family":"Salins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushma","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aparna","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipasri","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0973-1075.285693-1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jpainsymman.2006.01.001","article-title":"Low morphine doses in opioid-naive cancer patients with pain","author":"Mercadante","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"key-10.4103\/0973-1075.285693-2","first-page":"214","article-title":"The MERITO Study: A multicentre trial of the analgesic effect and tolerability of normal-release oral morphine during 'titration phase' in patients with cancer pain","author":"De","year":"2008","journal-title":"Palliat Med"},{"key":"key-10.4103\/0973-1075.285693-3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpainsymman.2007.12.016","article-title":"A double-blind, randomized, crossover comparison between single-dose and double-dose immediate-release oral morphine at bedtime in cancer patients","author":"Dale","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"key-10.4103\/0973-1075.285693-4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1191\/0269216303pm695oa","article-title":"Intravenous morphine for rapid control of severe cancer pain","author":"Harris","year":"2003","journal-title":"Palliat Med"},{"key":"key-10.4103\/0973-1075.285693-5","first-page":"212524","article-title":"Administration of intravenous morphine for acute pain in the emergency department inflicts an economic burden in Europe","author":"Casamayor","year":"2018","journal-title":"Drugs Context"},{"key":"key-10.4103\/0973-1075.285693-6","doi-asserted-by":"crossref","unstructured":"Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, et al. Use of opioid analgesics in the treatment of cancer pain: Evidence-based recommendations from the EAPC. Lancet Oncol 2012;13:e58-68.","DOI":"10.1016\/S1470-2045(12)70040-2"},{"key":"key-10.4103\/0973-1075.285693-7","first-page":"CD003868","article-title":"Oral morphine for cancer pain","author":"Wiffen","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0973-1075.285693-8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bmjspcare-2017-001467","article-title":"Breakthrough cancer pain (BTcP) management: A review of international and national guidelines","author":"Davies","year":"2018","journal-title":"BMJ Support Palliat Care"},{"key":"key-10.4103\/0973-1075.285693-9","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1001\/jama.1984.03350140051025","article-title":"Detecting alcoholism.The CAGE questionnaire","author":"Ewing","year":"1984","journal-title":"JAMA"},{"key":"key-10.4103\/0973-1075.285693-10","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the Opioid Risk Tool","author":"Webster","year":"2005","journal-title":"Pain Med"},{"key":"key-10.4103\/0973-1075.285693-11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpain.2006.03.001","article-title":"The DIRE score: Predicting outcomes of opioid prescribing for chronic pain","author":"Belgrade","year":"2006","journal-title":"J Pain"},{"key":"key-10.4103\/0973-1075.285693-12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0306-4603(82)90005-3","article-title":"The drug abuse screening test","author":"Skinner","year":"1982","journal-title":"Addict Behav"},{"key":"key-10.4103\/0973-1075.285693-13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jpain.2007.11.014","article-title":"Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R)","author":"Butler","year":"2008","journal-title":"J Pain"},{"key":"key-10.4103\/0973-1075.285693-14","first-page":"17","article-title":"Opioids pain management and addiction","author":"Schneider","year":"2006","journal-title":"Pain Pract Winter"},{"key":"key-10.4103\/0973-1075.285693-15","unstructured":"Gazette Notification G.S.R. 359(E) dated 5th May 2015 Issued Amending the Narcotic Drugs and Psychotropic Substances Rules, 1985, Namely Called the Narcotic Drugs and Psychotropic Substances (Third Amendment) Rules; 2015."},{"key":"key-10.4103\/0973-1075.285693-16","doi-asserted-by":"crossref","unstructured":"Passik SD, Weinreb HJ. Managing chronic nonmalignant pain: Overcoming obstacles to the use of opioids. Adv Ther 2000;17:70-83.","DOI":"10.1007\/BF02854840"},{"key":"key-10.4103\/0973-1075.285693-17","doi-asserted-by":"crossref","unstructured":"Deandrea S, Corli O, Consonni D, Villani W, Greco MT, Apolone G. Prevalence of breakthrough cancer pain: A systematic review and a pooled analysis of published literature. J Pain Symptom Manage 2014;47:57-76.","DOI":"10.1016\/j.jpainsymman.2013.02.015"},{"key":"key-10.4103\/0973-1075.285693-18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/ejp.612","article-title":"Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain","author":"Sperlinga","year":"2015","journal-title":"Eur J Pain"},{"key":"key-10.4103\/0973-1075.285693-19","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1177\/0269216310385601","article-title":"Opioids for the management of breakthrough cancer pain in adults: A systematic review undertaken as part of an EPCRC opioid guidelines project","author":"Zeppetella","year":"2011","journal-title":"Palliat Med"},{"key":"key-10.4103\/0973-1075.285693-20","first-page":"CDOO4311","article-title":"Opioids for the management of breakthrough episodic pain in cancer patients","author":"Zeppetella","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0973-1075.285693-21","doi-asserted-by":"crossref","unstructured":"Jandhyala R, Fullarton JR, Bennett MI. Efficacy of rapid-onset oral fentanyl formulations vs. oral morphine for cancer-related breakthrough pain: A meta-analysis of comparative trials. J Pain Symptom Manage 2013;46:573-80.","DOI":"10.1016\/j.jpainsymman.2012.09.009"},{"key":"key-10.4103\/0973-1075.285693-22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s12325-012-0051-7","article-title":"Opioid rotation in clinical practice","author":"Nalamachu","year":"2012","journal-title":"Adv Ther"},{"key":"key-10.4103\/0973-1075.285693-23","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jpainsymman.2009.06.001","article-title":"Opioid rotation: The science and the limitations of the equianalgesic dose table","author":"Knotkova","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"key-10.4103\/0973-1075.285693-24","first-page":"135","article-title":"Opioid rotation in cancer pain treatment","author":"Schuster","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"key-10.4103\/0973-1075.285693-25","unstructured":"Scottish Intercollegiate Guidelines Network. Control of Pain in Adults with Cancer. Edinburgh: Scottish Intercollegiate Guidelines Network; 2008."},{"key":"key-10.4103\/0973-1075.285693-26","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1089\/jpm.2007.0200","article-title":"Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: A meta-analysis and systematic review of the literature","author":"Tassinari","year":"2008","journal-title":"J Palliat Med"},{"key":"key-10.4103\/0973-1075.285693-27","doi-asserted-by":"crossref","unstructured":"Radbruch L, Trottenberg P, Elsner F, Kaasa S, Caraceni A. Systematic review of the role of alternative application routes for opioid treatment for moderate to severe cancer pain: An EPCRC opioid guidelines project. Palliat Med 2011;25:578-96.","DOI":"10.1177\/0269216310383739"},{"key":"key-10.4103\/0973-1075.285693-28","doi-asserted-by":"crossref","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","article-title":"Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines","author":"Fallon","year":"2018","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0973-1075.285693-29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jpainsymman.2009.06.004","article-title":"Opioid equianalgesic tables: Are they all equally dangerous?","author":"Shaheen","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"key-10.4103\/0973-1075.285693-30","doi-asserted-by":"crossref","first-page":"87s","DOI":"10.1200\/JCO.2003.01.183","article-title":"Opioid rotation in the management of refractory cancer pain","author":"Indelicato","year":"2003","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1075.285693-31","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1177\/0269216308096908","article-title":"The management of constipation in palliative care: Clinical practice recommendations","author":"Larkin","year":"2008","journal-title":"Palliat Med"},{"key":"key-10.4103\/0973-1075.285693-32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11916-001-0037-7","article-title":"Management of opioid-induced constipation","author":"Thorpe","year":"2001","journal-title":"Curr Pain Headache Rep"},{"key":"key-10.4103\/0973-1075.285693-33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jpainsymman.2004.06.013","article-title":"Constipation management in palliative care: A survey of practices in the United Kingdom","author":"Goodman","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"key-10.4103\/0973-1075.285693-34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.gtc.2009.06.001","article-title":"Chronic constipation in the elderly","author":"Bouras","year":"2009","journal-title":"Gastroenterol Clin North Am"},{"key":"key-10.4103\/0973-1075.285693-35","first-page":"90","article-title":"Prevalence of symptoms in older cancer patients receiving palliative care: A systematic review and meta-analysis","author":"Van","year":"2014","journal-title":"J Pain Symptom Manage"},{"key":"key-10.4103\/0973-1075.285693-36","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/j.1572-0241.2003.07591.x","article-title":"Association between physical activity, fiber intake, and other lifestyle variables and constipation in a study of women","author":"Dukas","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"key-10.4103\/0973-1075.285693-37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp.74.1.13","article-title":"Constipation in neurological diseases","author":"Winge","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/0973-1075.285693-38","doi-asserted-by":"crossref","first-page":"j3313","DOI":"10.1136\/bmj.j3313","article-title":"Pharmacological therapies for opioid induced constipation in adults with cancer","author":"Boland","year":"2017","journal-title":"BMJ"},{"key":"key-10.4103\/0973-1075.285693-39","doi-asserted-by":"crossref","first-page":"E13053","DOI":"10.1111\/nmo.13053","article-title":"What's new in Rome IV?","author":"Tack","year":"2017","journal-title":"J Neurogastroenterol Motil"},{"key":"key-10.4103\/0973-1075.285693-40","first-page":"CD003448","article-title":"Laxatives or methylnaltrexone for the management of constipation in palliative care patients","author":"Candy","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0973-1075.285693-41","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1310246","article-title":"Naloxegol for opioid-induced constipation in patients with noncancer pain","author":"Chey","year":"2014","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0973-1075.285693-42","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1200\/JCO.2017.73.0853","article-title":"Randomized phase III and extension studies of naldemedine in patients with opioid-induced constipation and cancer","author":"Katakami","year":"2017","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1075.285693-43","unstructured":"Sizar O, Gupta M. Opioid induced constipation. In: Stat Pearls. Treasure Island (FL): Stat Pearls Publishing; 2019. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK493184. [Last updated on 2019 Jun 04]."},{"key":"key-10.4103\/0973-1075.285693-44","first-page":"CD006938","article-title":"Droperidol for treatment of nausea and vomiting in palliative care patients","author":"Storrar","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0973-1075.285693-45","first-page":"CD009420","article-title":"Levomepromazine for nausea and vomiting in palliative care","author":"Cox","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0973-1075.285693-46","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/jpm.2015.0224","article-title":"Olanzapine in the management of difficult to control nausea and vomiting in a palliative care population: A case series","author":"MacKintosh","year":"2016","journal-title":"J Palliat Med"},{"key":"key-10.4103\/0973-1075.285693-47","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1089\/jpm.2014.0030","article-title":"Olanzapine for intractable nausea and vomiting in palliative care patients not receiving chemotherapy","author":"Atkinson","year":"2014","journal-title":"J Palliat Med"},{"key":"key-10.4103\/0973-1075.285693-48","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/IGC.0b013e318244ce93","article-title":"A prospective study on the efficacy of octreotide in the management of malignant bowel obstruction in gynecologic cancer","author":"Watari","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"key-10.4103\/0973-1075.285693-49","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.7314\/APJCP.2013.14.12.7107","article-title":"Clinical impact of palliative treatment using octreotide for inoperable malignant bowel obstruction caused by advanced urological cancer","author":"Kubota","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"key-10.4103\/0973-1075.285693-50","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12957-015-0455-3","article-title":"Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer","author":"Peng","year":"2015","journal-title":"World J Surg Oncol"},{"key":"key-10.4103\/0973-1075.285693-51","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/jjco\/hyq048","article-title":"Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction","author":"Hisanaga","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"key-10.4103\/0973-1075.285693-52","doi-asserted-by":"crossref","unstructured":"McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K, Gialeli-Goudas M, Chew PW, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: A systematic review. J Pain 2003;4:231-56.","DOI":"10.1016\/S1526-5900(03)00556-X"},{"key":"key-10.4103\/0973-1075.285693-53","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0952-8180(02)00501-9","article-title":"Neuraxial opioid-induced pruritus: A review","author":"Szarvas","year":"2003","journal-title":"J Clin Anesth"},{"key":"key-10.4103\/0973-1075.285693-54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2044.1993.tb06785.x","article-title":"Histamine release by morphine and diamorphine in man","author":"Withington","year":"1993","journal-title":"Anaesthesia"},{"key":"key-10.4103\/0973-1075.285693-55","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.6004\/jnccn.2010.0076","article-title":"Adult cancer pain","author":"Swarm","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"key-10.4103\/0973-1075.285693-56","first-page":"CD011056","article-title":"Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain","author":"Wiffen","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0973-1075.285693-57","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1200\/JCO.2001.19.9.2542","article-title":"Strategies to manage the adverse effects of oral morphine: An evidence-based report","author":"Cherny","year":"2001","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1075.285693-58","first-page":"1347","article-title":"Management of common opioid-induced adverse effects","author":"Swegle","year":"2006","journal-title":"Am Fam Physician"},{"key":"key-10.4103\/0973-1075.285693-59","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00365854","article-title":"A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics","author":"Wilwerding","year":"1995","journal-title":"Support Care Cancer"},{"key":"key-10.4103\/0973-1075.285693-60","first-page":"S16","article-title":"Strategies for limiting the side effects of cancer pain therapy","author":"Lyss","year":"1997","journal-title":"Semin Oncol"},{"key":"key-10.4103\/0973-1075.285693-61","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/01.NAJ.0000513528.79557.33","article-title":"Monitoring hospitalized adult patients for opioid-induced sedation and respiratory depression","author":"Jungquist","year":"2017","journal-title":"Am J Nurs"},{"key":"key-10.4103\/0973-1075.285693-62","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/ALN.0b013e3181c38c25","article-title":"Incidence, reversal, and prevention of opioid-induced respiratory depression","author":"Dahan","year":"2010","journal-title":"Anesthesiology"}],"container-title":["Indian Journal of Palliative Care"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T14:27:31Z","timestamp":1723127251000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpalliativecare.com\/indian-society-for-study-of-pain-cancer-pain-special-interest-group-guidelines-on-pharmacological-management-of-cancer-pain-part-ii\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"alternative-id":["285693"],"URL":"https:\/\/doi.org\/10.4103\/0973-1075.285693","relation":{},"ISSN":["0973-1075"],"issn-type":[{"value":"0973-1075","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}